Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (69)

Latest Posts

About This Stock More About This Stock
5 Top-Ranked Stocks Driving ETF As S&P 500 Nears New Highs
Article By: Sweta Killa
Thursday, August 13, 2020 12:00 PM EDT
Though most stocks in the fund’s portfolio are in the green this year, here are five that are leading the way in the SPY ETF.
In this article: ROL, WST, REGN, CDNS, PYPL Also: SPY
Read
Regeneron (REGN) Tops Q2 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Wednesday, August 5, 2020 10:09 AM EDT
Regeneron came out with quarterly earnings of $7.16 per share.
In this article: REGN
Read
REGN Flat Despite Covid-19 Antibody Drug Update
Article By: Schaeffers Research
Tuesday, August 4, 2020 11:00 AM EDT
The equity is up over 115% year-over-year.
In this article: REGN
Read
Quick Reminder: Insider Trading Does Not Maximize Shareholder Value
Article By: Dean Baker
Sunday, July 26, 2020 7:39 PM EDT
Insider trading effectively means top executives are stealing from the companies they run. Excitement over potential covid vaccines may be causing irregularities at at least 9 biopharmas, according to the NYT.
In this article: VXRT, REGN, MRNA, NVAX, LMNX, QDEL, EBS, INO
Read
Allakos Drops After Regeneron Eosinophilic Esophagitis Study Hits Endpoints
Article By: The Fly
Tuesday, May 26, 2020 12:17 PM EDT
Shares of Allakos are lower after Regeneron Pharmaceuticals announced yesterday that Part A of a Phase 3 trial evaluating Dupixent in patients 12 years and older with eosinophilic esophagitis met both of its co-primary endpoints.
In this article: REGN, ALLK
Read

PARTNER HEADLINES

Latest Tweets for $REGN

No tweets yet!

$REGN

Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments